Skip to main content

Table 7 Univariate analysis logistic regression analysis for the delay of initiation of antifibrotic treatment (≤ 1 year vs > 1 year). Patients diagnosed 1.6.2013 or after included

From: Overall drug treatment of idiopathic pulmonary fibrosis patients from national registries – a real-world study from Finland

Variable

OR

95% CI

p-value

Age 66–75 vs 50–65

0.83

0.27–2.54

0.74

Age over 75 vs 50–65

0.98

0.27–3.50

0.97

Age 66–75 vs over 75

0.85

0.29–2.46

0.76

Male vs female

0.51

0.20–1.29

0.15

FVC 75% or under vs FVC over 75%

5.63

1.93–16.46

0.0016

DLCO/VA over 55% vs DLCO/VA 55% or under

2.16

0.77–6.07

0.14

Other medicines 2–4 vs 0–1

0.62

0.10–3.66

0.59

Other medicines 5 or more vs 0–1

1.22

0.28–5.32

0.79

Other medicines 2–4 vs 5 or more

0.50

0.15–1.72

0.27